XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment from adoption of new accounting pronouncement
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative-effect adjustment from adoption of new accounting pronouncement
Accumulated Other Comprehensive Loss
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative-effect adjustment from adoption of new accounting pronouncement
Beginning balance (in shares) at Dec. 31, 2020     162,709,720            
Beginning balance at Dec. 31, 2020 $ 4,251,296   $ 1,627 $ 3,664,820   $ (20,201) $ 0 $ 605,050  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     1,412,919            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (76,881)   $ 14 (76,895)          
Stock Issued During Period, Shares, Employee Stock Purchase Plans     358,384            
Issuance of common stock under employee stock purchase plan 31,531   $ 4 31,527          
Stock-based compensation 124,291     124,291          
Repurchases of common stock (in shares)     (1,462,255)            
Repurchases of common stock (154,416)           (154,416)    
Net income 312,192             312,192  
Foreign currency translation adjustments (7,284)         (7,284)      
Change in unrealized loss on investments, net of tax (4,072)         (4,072)      
Ending balance (in shares) at Jun. 30, 2021     163,018,768            
Ending balance at Jun. 30, 2021 4,476,657   $ 1,645 3,743,743   (31,557) (154,416) 917,242  
Beginning balance (in shares) at Mar. 31, 2021     163,245,941            
Beginning balance at Mar. 31, 2021 4,321,363   $ 1,638 3,664,568   (47,347) (58,241) 760,745  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     284,735            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (12,875)   $ 3 (12,878)          
Stock Issued During Period, Shares, Employee Stock Purchase Plans     358,384            
Issuance of common stock under employee stock purchase plan 31,531   $ 4 31,527          
Stock-based compensation 60,526     60,526          
Repurchases of common stock (in shares)     (870,292)            
Repurchases of common stock (96,175)           (96,175)    
Net income 156,497             156,497  
Foreign currency translation adjustments 16,981         16,981      
Change in unrealized loss on investments, net of tax (1,191)         (1,191)      
Ending balance (in shares) at Jun. 30, 2021     163,018,768            
Ending balance at Jun. 30, 2021 4,476,657   $ 1,645 3,743,743   (31,557) (154,416) 917,242  
Beginning balance (in shares) at Dec. 31, 2021     160,512,111            
Beginning balance at Dec. 31, 2021 4,530,014 $ (235,427) $ 1,605 3,340,822 $ (375,414) (69,105) 0 1,256,692 $ 139,987
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     1,181,381            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (64,528)   $ 12 (64,540)          
Stock Issued During Period, Shares, Employee Stock Purchase Plans     335,644            
Issuance of common stock under employee stock purchase plan 29,308   $ 3 29,305          
Stock-based compensation 124,027     124,027          
Repurchases of common stock (in shares)     (2,559,308)            
Repurchases of common stock (267,642)           (267,642)    
Net income 238,700             238,700  
Foreign currency translation adjustments (47,242)         (47,242)      
Change in unrealized loss on investments, net of tax (26,732)         (26,732)      
Ending balance (in shares) at Jun. 30, 2022     159,469,828            
Ending balance at Jun. 30, 2022 4,280,478   $ 1,620 3,054,200   (143,079) (267,642) 1,635,379  
Beginning balance (in shares) at Mar. 31, 2022     160,535,769            
Beginning balance at Mar. 31, 2022 4,300,522   $ 1,615 2,974,529   (88,611) (102,853) 1,515,842  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)     233,231            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (9,889)   $ 2 (9,891)          
Stock Issued During Period, Shares, Employee Stock Purchase Plans     335,644            
Issuance of common stock under employee stock purchase plan 29,308   $ 3 29,305          
Stock-based compensation 60,257     60,257          
Repurchases of common stock (in shares)     (1,634,816)            
Repurchases of common stock (164,789)           (164,789)    
Net income 119,537             119,537  
Foreign currency translation adjustments (49,278)         (49,278)      
Change in unrealized loss on investments, net of tax (5,190)         (5,190)      
Ending balance (in shares) at Jun. 30, 2022     159,469,828            
Ending balance at Jun. 30, 2022 $ 4,280,478   $ 1,620 $ 3,054,200   $ (143,079) $ (267,642) $ 1,635,379